Integrated Analysis Reveals Prognostic Value and Immune Correlates of CD86 Expression in Lower Grade Glioma

BACKGROUND: CD86 has great potential to be a new target of immunotherapy by regulating cancer immune response. However, it remains unclear whether CD86 is a friend or foe in lower-grade glioma (LGG). METHODS: The prognostic value of CD86 expression in pan-cancer was analyzed using Cox regression and...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Huaide, Tian, Wei, He, Yikang, Li, Jiahui, He, Chuan, Li, Yongqiang, Liu, Ning, Li, Jianan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089378/
https://www.ncbi.nlm.nih.gov/pubmed/33954112
http://dx.doi.org/10.3389/fonc.2021.654350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089378/
https://www.ncbi.nlm.nih.gov/pubmed/33954112
http://dx.doi.org/10.3389/fonc.2021.654350

Ejemplares similares